QNTM
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Quantum BioPharma received FDA clearance to begin clinical trials for its investigational multiple sclerosis treatmentSep 10, 2026
- Quantum BioPharma received U.S. FDA clearance to proceed with the Phase 2 Lucid-MS trial in progressive multiple sclerosisAug 10, 2026
- Quantum BioPharma submitted an IND application to the FDA for a Phase 2 trial of Lucid-MS in multiple sclerosisApr 1, 2026
- Health Canada grants Quantum BioPharma a product license for its innovative product Qlarity™ that enhances energy, promotes metabolism, mental alertness, and cognitive performanceSep 18, 2025
- Quantum BioPharma signs agreement to manufacture oral drug formulation of potential breakthrough Lucid-21-302 for upcoming Phase 2 multiple sclerosis trialAug 11, 2025